Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction
Background: Newer therapeutic agents for type 2 diabetes mellitus can improve cardiovascular outcomes, but diabetes remains underdiagnosed in patients with myocardial infarction (MI). We sought to identify proteomic markers of undetected dysglycaemia (impaired fasting glucose, impaired glucose toler...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Upsala Medical Society
2019-07-01
|
Series: | Upsala Journal of Medical Sciences |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/03009734.2019.1650141 |